Abstract

Summary

This study demonstrates that melanopsin expression progressively declines in a rat model of retinitis pigmentosa, and that viral vector-mediated overexpression of melanopsin can partially restore retinal light sensitivity and delay visual function loss. These findings suggest melanopsin-based gene therapy could be a viable approach for preserving light sensitivity in degenerative retinal conditions, with potential implications for understanding ipRGC contributions to non-visual and visual light responses.
Abstract

Key Findings

  • Melanopsin protein expression was significantly reduced with increasing age in RCS rats due to loss of ipRGC dendritic axons.
  • Electroretinography b-wave amplitudes and light flash responses were significantly higher in AV-OPN4-GFP-injected eyes vs. AV-GFP controls at both 3 and 5 weeks post-injection (P<0.05).
  • Behavioral open-field testing confirmed that melanopsin overexpression reduced loss of light sensitivity in treated animals.
  • Sub-retinal injection of melanopsin overexpression vector delayed retinal degeneration and functional decline in an inherited RP model.
Categories

Categories

Eye Health & Vision: Investigates melanopsin overexpression as a therapeutic strategy to restore visual function in a retinitis pigmentosa animal model.
The Science of Light: Provides mechanistic insight into melanopsin's role in photoreception and its potential as a gene therapy target in retinal degeneration.
Authors

Author(s)

M Liu, J Dai, W Liu, C Zhao
Publication Date

Publication Year

2016
Citations

Number of Citations

6
View more publications